Overview

A Trial of SHR-1139 in Healthy Volunteers

Status:
RECRUITING
Trial end date:
2026-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, PK and immunogenicity profile of a single dose of SHR-1139 in healthy volunteers
Phase:
PHASE1
Details
Lead Sponsor:
Atridia Pty Ltd.